Cart
sales@molnova.com
SCH-37370
CAS No. 117796-52-8
SCH-37370( SCH 37370 | SCH37370 )
Catalog No. M23344 CAS No. 117796-52-8
SCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 176 | In Stock |
|
| 10MG | 251 | In Stock |
|
| 25MG | 452 | In Stock |
|
| 50MG | 655 | In Stock |
|
| 100MG | 888 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCH-37370
-
NoteResearch use only, not for human use.
-
Brief DescriptionSCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine.
-
DescriptionSCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine. Sch 37370 blocks the binding of [3H]pyrilamine to histamine-H1 receptors in rat brain membranes. Sch 37370 selectively inhibits PAF-induced aggregation of human platelets (IC50 : 0.6 mM) and also competes with PAF binding to specific sites in membrane preparations from human lungs (IC50 : 1.2 mM).
-
In Vitro——
-
In Vivo——
-
SynonymsSCH 37370 | SCH37370
-
PathwayOthers
-
TargetOther Targets
-
RecptorPAF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117796-52-8
-
Formula Weight352.86
-
Molecular FormulaC21H21ClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCC(N(CC1)CCC1=C(c(cc1)c(CC2)cc1Cl)c1c2cccn1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kaminski JJ, Carruthers NI, Wong SC, Chan TM, Billah MM, Tozzi S, McPhail AT. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine. Bioorg Med Chem. 1999 Jul;7(7):1413-23. PubMed PMID: 10465415.
molnova catalog
related products
-
glatiramer Acetate
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS).
-
Arjunetin
Arjunetin, an insect feeding-deterrent and growth inhibitor, shows antioxidant and anti-inflammatory activities.
-
MD2-IN-1
MD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD of 189 ?μM for the recombinant human MD2 (rhMD2).
